There are few things in Irish business policy as quietly powerful as the research and development tax credit. It does not make headlines the way a new factory does, but it shapes decisions in thousands of companies every year — from global pharma giants to ten-person software firms.

In Budget 2026, the Government made the credit more generous. The rate rose from 30% to 35%, and the amount a company can claim back as cash in the first year went up from €75,000 to €87,500. Revenue has since updated its guidance to reflect the changes, and the Department of Finance has set out its thinking in a published update in January 2026.

Here is what that means in plain language, who benefits, and why it matters for the next wave of Irish innovation.

How the R&D Tax Credit Works

The idea behind the credit is simple. Research is expensive and risky. Many experiments fail, and the ones that succeed can take years to pay off. The State wants companies to take on that risk here in Ireland, so it shares part of the cost through the tax system.

When a company spends money on qualifying research and development — salaries of the engineers and scientists doing the work, materials, some equipment and certain buildings — it can claim a percentage of that spend back as a tax credit. That credit reduces its corporation tax bill.

Crucially, companies that are not yet profitable, or are not paying much tax, can still benefit. The credit can be paid out as cash in instalments, which is especially important for startups and scale-ups that are spending heavily on development before they have much revenue.

To qualify, the work has to be genuine research and development. It must aim to achieve a scientific or technological advance and involve resolving real uncertainty. Routine work, cosmetic changes or simply buying off-the-shelf technology does not count.

The credit has been part of the Irish tax system for more than two decades and has been adjusted several times as the Government responded to international competition for research investment. Every change has been aimed at the same goal: making Ireland one of the most attractive places in Europe to carry out serious research and development.

It sits alongside other supports, such as Enterprise Ireland's research grants and the Knowledge Development Box, as part of a wider package that helps companies turn ideas into products and products into exports.

What Changed in Budget 2026

The first change is the rate. The credit is now worth 35% of qualifying spend, up from 30%. Put simply, for every €100 a company spends on qualifying R&D, it can now get €35 back instead of €30. For a company spending €1 million a year on research, that is an extra €50,000 in value.

The second change is the first-year payment threshold. Under the rules, a company can claim a set amount of its credit back as cash in the first year, with the rest paid over later years. That first-year amount has risen from €75,000 to €87,500.

For smaller companies, this second change may matter even more than the headline rate. Cash flow is the lifeblood of young innovative businesses. Getting more money back sooner means more runway, more hires and more room to experiment without constantly chasing the next funding round.

Citizens Information, Revenue and the Department of Finance have all confirmed the new figures, and Revenue's updated guidance sets out how companies should apply them in practice.

It is worth stressing that the changes are about more than generosity. Countries around the world are competing hard for research-intensive investment, and many have sharpened their own incentives in recent years. Keeping Ireland's credit competitive helps protect the research jobs already here and gives the country a stronger hand when new projects are being decided.

The Department of Finance has framed the move as part of a longer-term effort to support innovation and productivity across the economy, not only in the largest companies.

Who Benefits Most

The big multinationals with major research operations in Ireland will certainly benefit. Pharma, medtech and technology companies run significant R&D teams here, and a higher credit makes it easier for their Irish sites to win research mandates against sister sites in other countries.

But the real winners may be Irish-owned companies. Startups coming out of the Enterprise Ireland pipeline, university spinouts moving from lab to product and established Irish SMEs trying to modernise their offering all rely on the credit to make research affordable.

Take a young deep tech company building new chip designs or quantum hardware. Most of its spending in the early years goes on highly skilled people doing genuine research. A 35% credit, with more of it paid in cash up front, directly extends how long that company can keep building before it needs new investment.

The change also fits with the wider picture of Irish innovation policy. The Silicon Island semiconductor strategy, the Quantum 2030 implementation plan and a steady flow of Enterprise Ireland-backed startups all depend on companies being willing to invest in research here. A stronger credit supports every one of them.

Established Irish SMEs stand to gain as well. Food producers developing new products, engineering firms designing better machinery and software companies building new platforms can all find that parts of their work qualify. For many of these businesses, the credit can be the difference between shelving a new idea and pursuing it.

There is a regional benefit too. Research activity supported by the credit happens right across the country, from medtech clusters in Galway and Limerick to pharma sites in Cork and technology companies in the midlands.

How to Make the Most of It

The credit is only valuable if companies claim it properly. That means keeping good records from the start: what the project is trying to achieve, what the technical uncertainty is, who worked on it and how much time they spent.

Many companies, especially smaller ones, underclaim because they assume their work does not count or because the paperwork feels daunting. In reality, a lot of everyday engineering and product development in software, manufacturing, food and life sciences can qualify if it genuinely pushes the boundaries of what the company knows how to do.

Revenue's guidance sets out clearly what qualifies and what does not, and specialist advisers work with companies of every size on claims. For any business that invests in developing new products or processes, it is well worth a fresh look at the credit under the new rates.

The key message for founders and finance teams is simple: if you are doing real research in Ireland, the State is now paying a bigger share of the bill, and paying more of it sooner.

Timing matters as well. Companies generally need to make their claim within a set period after the end of the accounting year in which the spend happened, so building the claim into the normal year-end process is the simplest way to make sure nothing is missed.

For startups working with Enterprise Ireland, development advisers can also point founders towards the right help, making it easier to put the credit to work from the company's very first year.

The Bottom Line

Budget 2026 lifted Ireland's R&D tax credit from 30% to 35% and raised the first-year cash payment threshold from €75,000 to €87,500, changes now confirmed in Revenue guidance and by the Department of Finance. For big companies, it makes Ireland a more attractive place to win research work. For startups and SMEs, it means more cash, sooner, to build new products. It is one of the clearest signals yet that Ireland wants the next wave of innovation invented here, not just sold here.